Top Industry Leaders in the Cubital Tunnel Syndrome Market
AI-powered diagnostic tools Companies like AiQSmart and NeuralMetrics are developing AI algorithms that analyze nerve conduction studies and other data to aid in earlier and more accurate CTS diagnosis.
VRHealth and PhysioVR are creating VR programs to help patients with CTS regain hand function and improve their range of motion.
Stryker acquires Mobius Medical move strengthens Stryker's portfolio of nerve decompression implants and instruments, offering surgeons more options for treating CTS.
Medtronic partners with Verve Medical collaboration focuses on developing new technologies for nerve stimulation and regeneration, potentially leading to novel treatment options for CTS in the future.
List of Cubital Tunnel Syndrome Key Companies in the Market
- Eli Lily and Company (US)
- GlaxoSmithKline PLC (UK)
- Pfizer Inc.
- Depomed Inc.
- Novartis International AG (Switzerland)
- Johnson & Johnson Services Inc. (US)
- Bristol-Myers Squibb and Company (US)
- Sanofi S.A. (France)
- Debiopharm Group (Switzerland)
- Baxter Healthcare Corporation (US)
- Biogen Idec Inc. (US)
- Amneal Pharmaceuticals LLC. (US)
- Amgen Inc. (US)